Geneid T-Test Q-Val Gene Symbol Gene Title GO Biological Process

Total Page:16

File Type:pdf, Size:1020Kb

Geneid T-Test Q-Val Gene Symbol Gene Title GO Biological Process Supplementary Table 2. Genes selected by FADA as the most discriminant between tumoral and normal prostate samples GO Biological Process GO Molecular Function GO Cellular Component GeneID T-test q-val Gene Symbol Gene Title Description Description Description Pathway serine-type endopeptidase inhibitor activity /// endopeptidase inhibitor serpin peptidase inhibitor, clade activity /// serine-type endopeptidase 213572_s_at -6.753 2.213E-05 SERPINB1 B (ovalbumin), member 1 --- inhibitor activity cytoplasm --- ion transport /// cellular defense response /// positive regulation of T-cell, immune regulator 1, cell proliferation /// proton plasma membrane /// integral to ATPase, H+ transporting, transport /// transport /// proton transporter activity /// hydrogen ion plasma membrane /// membrane /// 204158_s_at -5.729 8.585E-05 TCIRG1 lysosomal V0 subunit A3 transport transporter activity integral to membrane --- chemotaxis /// cell adhesion /// homophilic cell adhesion /// nervous system development /// cell differentiation /// positive roundabout, axon guidance regulation of axonogenesis /// receptor activity /// axon guidance integral to plasma membrane /// cell receptor, homolog 1 development /// nervous system receptor activity /// identical protein surface /// membrane /// integral to 213194_at -6.168 4.441E-05 ROBO1 (Drosophila) development binding /// protein binding membrane --- structural molecule activity /// nucleus /// intermediate filament /// protein binding /// microtubule cytoplasmic dynein complex /// 203411_s_at -5.297 1.636E-04 LMNA lamin A/C --- motor activity /// motor activity microtubule /// dynein complex --- transcription factor activity /// skeletal development /// sequence-specific DNA binding /// v-ets erythroblastosis virus E26 regulation of transcription, DNA- DNA binding /// transcription factor Smooth_muscle_contrac 201329_s_at -5.807 7.442E-05 ETS2 oncogene homolog 2 (avian) dependent activity /// DNA binding nucleus tion nucleotide binding /// catalytic activity /// 6-phosphofructo-2-kinase activity /// 6-phosphofructo-2-kinase activity /// fructose-2,6-bisphosphate 2-phosphatase activity /// fructose- 2,6-bisphosphate 2-phosphatase fructose 2,6-bisphosphate activity /// ATP binding /// kinase Fructose and mannose 6-phosphofructo-2- metabolism /// fructose 2,6- activity /// transferase activity /// metabolism /// Fructose kinase/fructose-2,6- bisphosphate metabolism /// hydrolase activity /// identical and mannose 202464_s_at -5.034 2.458E-04 PFKFB3 biphosphatase 3 metabolism protein binding --- metabolism nucleotide binding /// DNA binding /// double-stranded DNA binding /// double-stranded DNA binding /// single-stranded DNA binding /// single-stranded DNA binding /// DNA replication /// DNA RNA binding /// RNA binding /// replication /// RNA processing /// protein binding /// identical protein regulation of translation /// binding /// magnesium ion binding RNA binding motif, single cytokine and chemokine /// protein serine/threonine kinase stranded interacting protein 1 /// mediated signaling pathway /// activity /// ATP binding /// nucleic chromosome 2 open reading regulation of protein complex acid binding /// magnesium ion frame 12 /// region containing disassembly /// protein amino binding /// protein kinase activity /// chromosome 2 open reading acid phosphorylation /// DNA protein serine/threonine kinase RBMS1 /// frame 12; RNA binding motif, replication /// protein amino acid activity /// protein binding /// ATP C2orf12 /// single stranded interacting phosphorylation /// signal binding /// kinase activity /// 215127_s_at -5.066 2.351E-04 LOC648293 protein 1 transduction transferase activity nucleus /// nucleus --- transcription /// regulation of transcription, DNA-dependent /// negative regulation of NGFI-A binding protein 1 transcription /// regulation of transcriptional repressor activity /// 209272_at -6.317 3.885E-05 NAB1 (EGR1 binding protein 1) transcription, DNA-dependent transcriptional repressor activity nucleus /// nucleus --- schwannomin interacting 204030_s_at -6.382 3.490E-05 SCHIP1 protein 1 --- --- cytoplasm --- immune response /// cell surface receptor linked signal CD59 molecule, complement transduction /// blood coagulation protein binding /// GPI anchor membrane fraction /// plasma 200984_s_at -5.554 1.108E-04 CD59 regulatory protein /// defense response binding membrane /// membrane --- nuclear envelope /// cytoplasm /// BCL2/adenovirus E1B 19kDa apoptosis /// anti-apoptosis /// GTPase activator activity /// calcium intracellular membrane-bound 209308_s_at -6.634 2.510E-05 BNIP2 interacting protein 2 apoptosis ion binding /// protein binding organelle --- phospholipase inhibitor activity /// phospholipase inhibitor activity /// calcium ion binding /// calcium- dependent phospholipid binding /// soluble fraction /// plasma Prostaglandin_synthesis 201590_x_at -5.916 6.118E-05 ANXA2 annexin A2 skeletal development cytoskeletal protein binding membrane _regulation plasma membrane /// integral to plasma membrane /// caveolar membrane /// caveolar membrane /// Integrin- protein binding /// protein lipid raft /// perinuclear region /// mediated_cell_adhesion 203323_at -6.351 3.721E-05 CAV2 caveolin 2 --- homodimerization activity membrane /// integral to membrane _KEGG Golgi membrane /// endoplasmic Integrin- reticulum /// integral to plasma mediated_cell_adhesion structural molecule activity /// membrane /// membrane /// integral _KEGG /// Integrin- caveolin 1, caveolae protein, cholesterol transport /// protein binding /// cholesterol to membrane /// caveolar membrane mediated_cell_adhesion 203065_s_at -5.982 5.829E-05 CAV1 22kDa cholesterol homeostasis binding /// caveolar membrane /// lipid raft _KEGG nuclear envelope /// plasma fer-1-like 3, myoferlin (C. membrane /// integral to membrane 201798_s_at -5.295 1.636E-04 FER1L3 elegans) muscle contraction /// circulation --- /// membrane --- membrane fraction /// endoplasmic ion transport /// chemotaxis /// reticulum /// endoplasmic reticulum proteolipid protein 2 (colonic cytokine and chemokine protein binding /// ion transporter membrane /// plasma membrane /// 201136_at -5.399 1.401E-04 PLP2 epithelium-enriched) mediated signaling pathway activity /// chemokine binding integral to membrane /// membrane --- regulation of progression through calcium ion binding /// growth factor cell cycle /// cell cycle /// signal activity /// protein homodimerization transduction /// cell-cell signaling activity /// S100 beta binding /// /// axonogenesis /// cell S100 alpha binding /// calcium- proliferation /// positive dependent protein binding /// protein S100 calcium binding protein regulation of fibroblast binding /// calcium ion binding /// ruffle /// nucleus /// nuclear Prostaglandin_synthesis 217728_at -6.577 2.637E-05 S100A6 A6 (calcyclin) proliferation /// cell cycle calcium ion binding envelope /// cytoplasm /// cytoplasm _regulation development /// cell death /// negative regulation of cell membrane fraction /// membrane /// 203729_at -5.347 1.505E-04 EMP3 epithelial membrane protein 3 proliferation /// cell growth --- integral to membrane --- coronin, actin binding protein, phagocytosis /// signal 221676_s_at -6.067 5.213E-05 CORO1C 1C transduction actin binding actin cytoskeleton --- Smooth_muscle_contrac nucleotide binding /// structural tion /// constituent of cytoskeleton /// Smooth_muscle_contrac AFFX- protein binding /// ATP binding /// cytoskeleton /// actin filament /// tion /// HSAC07/X00351 structural molecule activity /// TIP60 histone acetyltransferase Striated_muscle_contrac _5_at -5.296 1.636E-04 ACTB actin, beta --- protein binding complex tion lysosomal associated protein transmembrane 4 beta /// lysosomal associated protein 208029_s_at -6.207 4.242E-05 LAPTM4B transmembrane 4 beta --- --- integral to membrane --- G_Protein_Signaling /// A kinase (PRKA) anchor G_Protein_Signaling /// AKAP2 /// protein 2 /// PALM2-AKAP2 G_Protein_Signaling /// 202760_s_at -6.23 4.242E-05 PALM2-AKAP2 protein regulation of cell shape kinase activity /// enzyme binding membrane G_Protein_Signaling nucleotide binding /// 5'-nucleotidase activity /// zinc ion binding /// Purine metabolism /// hydrolase activity, acting on ester Pyrimidine metabolism bonds /// metal ion binding /// GPI /// Nicotinate and DNA metabolism /// nucleotide anchor binding /// 5'-nucleotidase nicotinamide 203939_at -5.15 2.046E-04 NT5E 5'-nucleotidase, ecto (CD73) catabolism activity /// hydrolase activity membrane fraction /// membrane metabolism fasciculation and elongation cell adhesion /// nervous system 203562_at -6.61 2.523E-05 FEZ1 protein zeta 1 (zygin I) development /// axon guidance protein binding --- --- squamous cell carcinoma endoplasmic reticulum /// 218854_at -5.984 5.829E-05 SART2 antigen recognized by T cells 2 --- --- membrane /// integral to membrane --- serine-type endopeptidase inhibitor nervous system development /// activity /// heparin binding /// serpin peptidase inhibitor, clade cell differentiation /// regulation endopeptidase inhibitor activity /// E (nexin, plasminogen activator of proteolysis /// regulation of cell serine-type endopeptidase inhibitor 212190_at -5.191 1.906E-04 SERPINE2 inhibitor type 1), member 2 migration /// development activity /// heparin binding extracellular region --- Circadian_Exercise /// Glutathione metabolism anti-apoptosis /// central nervous /// Metabolism of system development /// glutathione transferase activity /// xenobiotics by 200824_at -5.955 5.829E-05 GSTP1 glutathione S-transferase
Recommended publications
  • Next-Generation Sequencing of Representational Difference Analysis
    Planta DOI 10.1007/s00425-017-2657-0 ORIGINAL ARTICLE Next-generation sequencing of representational difference analysis products for identification of genes involved in diosgenin biosynthesis in fenugreek (Trigonella foenum-graecum) 1 1 1 1 Joanna Ciura • Magdalena Szeliga • Michalina Grzesik • Mirosław Tyrka Received: 19 August 2016 / Accepted: 30 January 2017 Ó The Author(s) 2017. This article is published with open access at Springerlink.com Abstract Within the transcripts related to sterol and steroidal Main conclusion Representational difference analysis saponin biosynthesis, we discovered novel candidate of cDNA was performed and differential products were genes of diosgenin biosynthesis and validated their sequenced and annotated. Candidate genes involved in expression using quantitative RT-PCR analysis. Based on biosynthesis of diosgenin in fenugreek were identified. these findings, we supported the idea that diosgenin is Detailed mechanism of diosgenin synthesis was biosynthesized from cycloartenol via cholesterol. This is proposed. the first report on the next-generation sequencing of cDNA-RDA products. Analysis of the transcriptomes Fenugreek (Trigonella foenum-graecum L.) is a valuable enriched in low copy sequences contributed substantially medicinal and crop plant. It belongs to Fabaceae family to our understanding of the biochemical pathways of and has a unique potential to synthesize valuable steroidal steroid synthesis in fenugreek. saponins, e.g., diosgenin. Elicitation (methyl jasmonate) and precursor feeding (cholesterol and squalene) were Keywords Diosgenin Á Next-generation sequencing Á used to enhance the content of sterols and steroidal Phytosterols Á Representational difference analysis of sapogenins in in vitro grown plants for representational cDNA Á Steroidal saponins Á Transcriptome user-friendly difference analysis of cDNA (cDNA-RDA).
    [Show full text]
  • Relating Metatranscriptomic Profiles to the Micropollutant
    1 Relating Metatranscriptomic Profiles to the 2 Micropollutant Biotransformation Potential of 3 Complex Microbial Communities 4 5 Supporting Information 6 7 Stefan Achermann,1,2 Cresten B. Mansfeldt,1 Marcel Müller,1,3 David R. Johnson,1 Kathrin 8 Fenner*,1,2,4 9 1Eawag, Swiss Federal Institute of Aquatic Science and Technology, 8600 Dübendorf, 10 Switzerland. 2Institute of Biogeochemistry and Pollutant Dynamics, ETH Zürich, 8092 11 Zürich, Switzerland. 3Institute of Atmospheric and Climate Science, ETH Zürich, 8092 12 Zürich, Switzerland. 4Department of Chemistry, University of Zürich, 8057 Zürich, 13 Switzerland. 14 *Corresponding author (email: [email protected] ) 15 S.A and C.B.M contributed equally to this work. 16 17 18 19 20 21 This supporting information (SI) is organized in 4 sections (S1-S4) with a total of 10 pages and 22 comprises 7 figures (Figure S1-S7) and 4 tables (Table S1-S4). 23 24 25 S1 26 S1 Data normalization 27 28 29 30 Figure S1. Relative fractions of gene transcripts originating from eukaryotes and bacteria. 31 32 33 Table S1. Relative standard deviation (RSD) for commonly used reference genes across all 34 samples (n=12). EC number mean fraction bacteria (%) RSD (%) RSD bacteria (%) RSD eukaryotes (%) 2.7.7.6 (RNAP) 80 16 6 nda 5.99.1.2 (DNA topoisomerase) 90 11 9 nda 5.99.1.3 (DNA gyrase) 92 16 10 nda 1.2.1.12 (GAPDH) 37 39 6 32 35 and indicates not determined. 36 37 38 39 S2 40 S2 Nitrile hydration 41 42 43 44 Figure S2: Pearson correlation coefficients r for rate constants of bromoxynil and acetamiprid with 45 gene transcripts of ECs describing nucleophilic reactions of water with nitriles.
    [Show full text]
  • ( 12 ) United States Patent
    US010208322B2 (12 ) United States Patent ( 10 ) Patent No. : US 10 ,208 , 322 B2 Coelho et al. (45 ) Date of Patent: * Feb . 19, 2019 ( 54 ) IN VIVO AND IN VITRO OLEFIN ( 56 ) References Cited CYCLOPROPANATION CATALYZED BY HEME ENZYMES U . S . PATENT DOCUMENTS 3 , 965 ,204 A 6 / 1976 Lukas et al. (71 ) Applicant: California Institute of Technology , 4 , 243 ,819 A 1 / 1981 Henrick Pasadena , CA (US ) 5 ,296 , 595 A 3 / 1994 Doyle 5 , 703 , 246 A 12 / 1997 Aggarwal et al. 7 , 226 , 768 B2 6 / 2007 Farinas et al. ( 72 ) Inventors : Pedro S . Coelho , Los Angeles, CA 7 , 267 , 949 B2 9 / 2007 Richards et al . (US ) ; Eric M . Brustad , Durham , NC 7 ,625 ,642 B2 12 / 2009 Matsutani et al. (US ) ; Frances H . Arnold , La Canada , 7 ,662 , 969 B2 2 / 2010 Doyle et al. CA (US ) ; Zhan Wang , San Jose , CA 7 ,863 ,030 B2 1 / 2011 Arnold (US ) ; Jared C . Lewis , Chicago , IL 8 ,247 ,430 B2 8 / 2012 Yuan 8 , 993 , 262 B2 * 3 / 2015 Coelho . .. .. .. • * • C12P 7 /62 (US ) 435 / 119 9 ,399 , 762 B26 / 2016 Farwell et al . (73 ) Assignee : California Institute of Technology , 9 , 493 ,799 B2 * 11 /2016 Coelho .. C12P 7162 Pasadena , CA (US ) 2006 / 0030718 AL 2 / 2006 Zhang et al. 2006 / 0111347 A1 5 / 2006 Askew , Jr . et al. 2007 /0276013 AL 11 /2007 Ebbinghaus et al . ( * ) Notice : Subject to any disclaimer , the term of this 2009 /0238790 A2 9 /2009 Sommadosi et al. patent is extended or adjusted under 35 2010 / 0056806 A1 3 / 2010 Warren U .
    [Show full text]
  • SUPPLEMENTARY MATERIAL Supplementary Table 1
    Predicting Drug Promiscuity Using Spherical Harmonic Surface The Open Conference Proceedings Journal, 2011, Volume 2 i SUPPLEMENTARY MATERIAL Supplementary Table 1. MDDR Target Annotations Used in the Promiscuity Predictions TARGET_KEY EXTERNAL_ID 1001 prostaglandin-endoperoxide synthase 1002 cyclooxygenase 1 1003 cyclooxygenase 2 1046 ribonucleoside-diphosphate reductase 1112 thymidylate synthase 1209 phosphoribosylglycinamide formyltransferase 1609 purine-nucleoside phosphorylase 1611 uridine phosphorylase 1637 nad adp-ribosyltransferase 1657 transferring alkyl or aryl groups, other than methyl groups 1798 thymidine kinase 1814 protein kinase 1843 1-phosphatidylinositol 4-kinase 1883 protein-tyrosine kinase 1973 nucleotidyltransferase 2018 rna-directed dna polymerase 2121 phospholipase a2 2124 acetylcholinesterase 2282 phosphoric diester hydrolase 2283 phosphodiesterase i 2309 3',5'-cyclic-nucleotide phosphodiesterase 2310 3',5'-cyclic-gmp phosphodiesterase 2316 steryl-sulfatase 2414 alpha-glucosidase 2565 adenosylhomocysteinase 2576 peptidase 25 aldehyde reductase 2613 dipeptidyl-peptidase iv 2619 peptidyl-dipeptidase a 2624 serine-type d-ala-d-ala carboxypeptidase 2659 serine endopeptidase 2663 trypsin 2664 thrombin 2665 coagulation factor xa 2672 coagulation factor viia 2695 tryptase 2742 cathepsin b 2750 cathepsin l 2765 caspase-1 2784 hiv-1 retropepsin 2811 metalloendopeptidase 2822 stromelysin 1 286 xanthine oxidase 2978 beta-lactamase 3014 adenosine deaminase ii The Open Conference Proceedings Journal, 2011, Volume 2 Pérez-Nueno
    [Show full text]
  • Dalmanol Biosyntheses Require Coupling of Two Separate Polyketide Gene Clusters
    Showcasing research progress from Professor Ren Xiang Tan’s As featured in: laboratories at Nanjing University & Nanjing University of Chinese Medicine, Nanjing, China. Dalmanol biosyntheses require coupling of two separate polyketide gene clusters The biosynthesis of immunosuppressants (dalmanol A and acetodalmanol A) is characterized by the coupling of two separate (naphthalene- and chromane-encoding) gene clusters under the catalysis of unspecifi c enzyme(s) that may distribute widely in the fungal kingdom. The fi nding highlights an access to the inter-cluster orchestration derived chemodiversity of microbial secondary metabolites that remain to be a reliable source of leading compounds triggering the development of See Ren Xiang Tan et al., new medicines, agrochemicals, and other tool molecules. Chem. Sci., 2019, 10, 73. rsc.li/chemical-science Registered charity number: 207890 Chemical Science View Article Online EDGE ARTICLE View Journal | View Issue Dalmanol biosyntheses require coupling of two separate polyketide gene clusters† Cite this: Chem. Sci.,2019,10,73 a a bc a a All publication charges for this article Zhen Zhen Zhou, Hong Jie Zhu, Li Ping Lin, Xuan Zhang, Hui Ming Ge, have been paid for by the Royal Society Rui Hua Jiaoa and Ren Xiang Tan *ab of Chemistry Polyketide–polyketide hybrids are unique natural products with promising bioactivity, but the hybridization processes remain poorly understood. Herein, we present that the biosynthetic pathways of two immunosuppressants, dalmanol A and acetodalmanol A, result from an unspecific monooxygenase triggered hybridization of two distinct polyketide (naphthalene and chromane) biosynthetic gene clusters. The orchestration of the functional dimorphism of the polyketide synthase (ChrA) ketoreductase (KR) domain (shortened as ChrA KR) with that of the KR partner (ChrB) in the bioassembly line increases the polyketide diversity and allows the fungal generation of plant chromanes (e.g., noreugenin) and phloroglucinols (e.g., 2,4,6-trihydroxyacetophenone).
    [Show full text]
  • A Network-Based Analysis of Traditional Chinese Medicine Cold and Hot Patterns in Rheumatoid Arthritis
    A Network-Based Analysis of Traditional Chinese Medicine Cold and Hot Patterns in Rheumatoid Arthritis By: Gao Chen, Cheng Lu, Qinglin Zha, Cheng Xiao, Shijie Xu, Dahong Ju, Youwen Zhou, Wei Jia, and Aiping Lu Chen, G., Lu, Cheng, Zha, Q.L., Xiao, C., Xu, S.J., Ju, D.H., Zhou, Y.W., Jia, W., Lu, A.P. (2012). A network-based analysis of traditional Chinese medicine cold and hot patterns in rheumatoid arthritis, Complementary Therapies in Medicine, 20(1-2), 23-30. ***Note: This version of the document is not the copy of record. Made available courtesy of Elsevier. Link to Article: http://www.sciencedirect.com/science/article/pii/S0965229911001579 Abstract: Objective- Rheumatoid arthritis (RA) is a heterogeneous disease, and traditional Chinese medicine (TCM) can be used to classify RA into different patterns such as cold and hot based on its clinical manifestations. The aim of this study was to investigate potential network-based biomarkers for RA with either a cold or a hot pattern. Method- Microarray technology was used to reveal gene expression profiles in CD4+ T cells from 21 RA patients with cold pattern and 12 with hot pattern. A T-test was used to identify significant differences in gene expression among RA patients with either cold or hot pattern. Cytoscape software was used to search the existing literature and databases for protein–protein interaction information for genes of interest that were identified from this analysis. The IPCA algorithm was used to detect highly connected regions for inferring significant complexes or pathways in this protein–protein interaction network.
    [Show full text]
  • Abuse-Deterrent Pharmaceutical Compositions
    (19) TZZ¥ _Z¥Z_T (11) EP 3 210 630 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 30.08.2017 Bulletin 2017/35 A61K 47/36 (2006.01) A61K 9/14 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) (2006.01) (2006.01) (21) Application number: 16157803.4 A61K 31/455 A61K 31/485 (22) Date of filing: 29.02.2016 (84) Designated Contracting States: (71) Applicant: G.L. Pharma GmbH AL AT BE BG CH CY CZ DE DK EE ES FI FR GB 8502 Lannach (AT) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (72) Inventor: The designation of the inventor has not Designated Extension States: yet been filed BA ME Designated Validation States: (74) Representative: Sonn & Partner Patentanwälte MA MD Riemergasse 14 1010 Wien (AT) (54) ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS (57) Disclosed are pharmaceutical compositions comprising oxycodone and an oxycodone-processing enzyme, wherein oxycodone is contained in the pharmaceutical composition in a storage stable, enzyme-reactive state and under conditions wherein no enzymatic activity acts on oxycodone. EP 3 210 630 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 210 630 A1 Description [0001] The present application relates to abuse-deterrent pharmaceutical compositions comprising oxycodone. [0002] Prescription opioid products are an important component of modern pain management. However, abuse and 5 misuse of these products have created a serious and growing public health problem. One potentially important step towards the goal of creating safer opioid analgesics has been the development of opioids that are formulated to deter abuse.
    [Show full text]
  • Tumor-Normal (Log2) Gene Title 1559057 at -1.71 Chrx Orf45 205833 S at -1.73 Prostate Androgen-Regulated Transcript 1 223150 S A
    Tumor-Normal (log2) Gene Title 1559057_at -1.71 ChrX orf45 205833_s_at -1.73 Prostate androgen-regulated transcript 1 223150_s_at 0.98 protein tyrosine phosphatase, non-receptor type 23 204856_at 0.91 UDP-GlcNAc:betaGal beta-1,3-NAcGlctransferase 3 232932_at -1.44 Hypothetical protein LOC645030 237669_at -1.13 Protein tyrosine phosphatase domain containing 1 235041_at 0.81 golgi SNAP receptor complex member 2 243580_at 1.16 Guanine nucleotide binding protein (G protein), alpha 14 234354_x_at -1.28 erb-b2 (Her2) erythroblastic leukemia viral oncogene homolog 2 217228_s_at 1.07 ankyrin repeat and SOCS box-containing 4 232690_at -1.53 Mannosyl (alpha-1,3-)-glycoprotein 244371_at 1.36 Hypothetical protein MGC16169 204924_at 1.15 toll-like receptor 2 1559382_at 0.89 chr19 orf 42 239965_at 0.86 hypothetical protein LOC151878 202409_at 4.11 chr11 orf 43 235630_at 0.66 Transcribed locus 236879_at 0.79 Ubiquitin-activating enzyme E1-like 2 221237_s_at -1.59 oxysterol binding protein 2 230443_at -1.30 NHP2 non-histone chromosome protein 2-like 1 208250_s_at -0.70 deleted in malignant brain tumors 1 235814_at -1.18 Transcribed locus 231544_s_at -1.76 CDNA: FLJ21837 fis, clone HEP01664 243767_at 0.83 Transcribed locus 241865_at 0.72 G protein, beta polypeptide 1 237350_at -1.54 similar to CDNA sequence BC021608 227670_at -1.12 zinc finger protein 75a 217100_s_at 0.75 UBX domain containing 7 240422_at -1.19 Flavin containing monooxygenase 5 230000_at 0.87 chr17 orf 27 230599_at 0.80 Ring finger protein 19 204433_s_at -1.18 spermatogenesis associated
    [Show full text]
  • Supplementary File 1
    Electronic Supplementary Material (ESI) for Food & Function. This journal is © The Royal Society of Chemistry 2021 Supplementary File 1 Table S1 Targets corresponding to EACC components No. Gene ID Gene Symbol Description ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance 1 18671 Abcb1a protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1) ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1B) (Multidrug resistance protein 2 18669 Abcb1b 1B) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243) Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) 3 17250 Abcc1 (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter) Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette 4 26357 Abcg2 sub-family G member 2) (Breast cancer resistance protein 1 homolog) (Urate exporter) (CD antigen CD338) 5 27405 Abcg3 ATP-binding cassette sub-family G member 3 Monoacylglycerol lipase ABHD6 (EC 3.1.1.23) (2- 6 66082 Abhd6 arachidonoylglycerol hydrolase) (Abhydrolase domain- containing protein 6) Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson 7 11350 Abl1 murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha)
    [Show full text]
  • Alterations in Progesterone Catabolic Enzymes by Insulin
    Graduate Theses, Dissertations, and Problem Reports 2007 Alterations in progesterone catabolic enzymes by insulin Caleb Owens Lemley West Virginia University Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Lemley, Caleb Owens, "Alterations in progesterone catabolic enzymes by insulin" (2007). Graduate Theses, Dissertations, and Problem Reports. 2536. https://researchrepository.wvu.edu/etd/2536 This Thesis is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Thesis in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Thesis has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. Alterations in Progesterone Catabolic Enzymes by Insulin Caleb Owens Lemley Thesis submitted to the Davis College of Agriculture, Forestry and Consumer Sciences at West Virginia University in partial fulfillment of the requirements for the degree of Master of Science in Reproductive Physiology Matthew E. Wilson, Ph.D., Chair Kenneth P. Blemings, Ph.D. K. Marie Krause, Ph.D. Division of Animal and Nutritional Sciences Morgantown, WV 2007 Keywords: Progesterone Catabolism, Insulin, Glucagon, Cytochrome P450 ABSTRACT Alterations in Progesterone Catabolic Enzymes by Insulin Caleb Owens Lemley The current experiments were conducted to determine if insulin could alter the progesterone catabolic enzymes, cytochrome P450 2C and 3A in vitro, utilizing a mouse hepatocyte cell-line, or in vivo, utilizing the ovariectomized ewe as a model.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,993,262 B2 Coelho Et Al
    USOO8993262B2 (12) United States Patent (10) Patent No.: US 8,993,262 B2 Coelho et al. (45) Date of Patent: Mar. 31, 2015 (54) IN VIVO AND IN VITRO OLEFIN 2006/0030718 A1* 2/2006 Zhang et al. .................. 548,954 CYCLOPROPANATION CATALYZED BY 2006/01 11347 A1 5/2006 Askew, Jr. et al. 2007/0276013 A1 1 1/2007 Ebbinghaus et al. HEMIE ENZYMES 2009/0238790 A2 9/2009 Sommadossi et al. 2010.00568.06 A1 3/2010 Warren (71) Applicant: California Institute of Technology, 2010/0168463 A1 7, 2010 Hirata et al. Pasadena, CA (US) 2010/024010.6 A1 9/2010 Wong et al. 2011 0196086 A1 8, 2011 Matsushita et al. (72) Inventors: Pedro S. Coelho, Los Angeles, CA (US); 2012/0237591 A1 9, 2012 Cullis et al. Eric M. Brustad, Durham, NC (US); Frances H. Arnold, La Canada, CA FOREIGN PATENT DOCUMENTS (US); Zhan Wang. San Jose, CA (US); EP O 200 638 B1 4, 1986 Jared C. Lewis, Chicago, IL (US) WO 2007 144599 A2 12/2007 WO 2011, 1595.50 A3 12/2011 (73) Assignee: California Institute of Technology, Pasadena, CA (US) OTHER PUBLICATIONS (*) Notice: Subject to any disclaimer, the term of this Adams, P.D. et al., “PHENIX: a comprehensive Python-based system patent is extended or adjusted under 35 for macromolecular structure solution.” Acta Crystallogr., Sect. D, U.S.C. 154(b) by 0 days. R.JKumar, F.K.R. et R.O.al., 1soprenoid painwayNavonimation optimization Ioror taxoto (21) Appl. No.: 14/185.861 precursor overproduction in Escherichia coli,” Science, 2010, y x- - - 9 330:70-74.
    [Show full text]
  • Supplementary Information for a Proactive Genotype-To-Patient-Phenotype Map for Cystathionine Beta-Synthase
    Supplementary information for A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase Song Sun, Jochen Weile, Marta Verby, Atina G. Cote, Yingzhou Wu, Iosifina Fotiadou, Julia Kitaygorodsky, Jasper Rine, Pavel Ješina, Viktor Kožich, Frederick P. Roth Supplementary Figures Supplementary Figure 1. Expression of human CBS protein can rescue growth of yeast cys4D strain in the absence of exogenous cysteine. Growth of cys4D strain expressing CBS gene or carrying empty vector in non-selective (a) or selective (b) medium. The nonselective medium is synthetic complete medium lacking cysteine and supplemented with glutathione, a stable source of cysteine. The selective medium is synthetic complete medium lacking cysteine and glutathione. All medium was supplemented with galactose as carbon source to induce the expression. 1 Supplementary Figure 2. VE map fitness scores are in good agreement with relative growth rates determined in single-variant assays and strong correlation between VE map fitness scores with low concentrations of vitamin B6. (a-c) Correlation between fitness scores from VE maps and relative growth rates from single-variant assays at three different vitamin B6 concentrations. (d) Correlation between fitness scores from high vitamin B6 VE map and Cys-/Cys+ growth ratios from single-variant assays. (e) Correlation between VE map fitness scores with 0 and 1 ng/ml vitamin B6. The correlation test is Pearson correlation. 2 Supplementary Figure 3. VE maps for CBS before computational imputation and refinement: fitness landscape with low level of vitamin B6 (top), fitness landscape with high level of vitamin B6 (middle) and delta fitness (high-low vitamin B6) landscape (bottom).
    [Show full text]